284 related articles for article (PubMed ID: 32835479)
1. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
[TBL] [Abstract][Full Text] [Related]
2. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
3. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
4. Improving vaccines against
Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
[No Abstract] [Full Text] [Related]
5. A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.
Parameswarappa SG; Reppe K; Geissner A; Ménová P; Govindan S; Calow ADJ; Wahlbrink A; Weishaupt MW; Monnanda BP; Bell RL; Pirofski LA; Suttorp N; Sander LE; Witzenrath M; Pereira CL; Anish C; Seeberger PH
Cell Chem Biol; 2016 Nov; 23(11):1407-1416. PubMed ID: 27818299
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides.
Geissner A; Pereira CL; Leddermann M; Anish C; Seeberger PH
ACS Chem Biol; 2016 Feb; 11(2):335-44. PubMed ID: 26674834
[TBL] [Abstract][Full Text] [Related]
7. Semisynthetic glycoconjugate vaccine candidate against
Lisboa MP; Khan N; Martin C; Xu FF; Reppe K; Geissner A; Govindan S; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11063-11068. PubMed ID: 28973947
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic Glycoconjugate Vaccines To Elicit T Cell-Mediated Immune Responses and Protection against
Feng S; Xiong C; Wang S; Guo Z; Gu G
ACS Infect Dis; 2019 Aug; 5(8):1423-1432. PubMed ID: 31126171
[No Abstract] [Full Text] [Related]
9. Identification of the Minimal Glycotope of Streptococcus pneumoniae 7F Capsular Polysaccharide using Synthetic Oligosaccharides.
Ménová P; Sella M; Sellrie K; Pereira CL; Seeberger PH
Chemistry; 2018 Mar; 24(16):4181-4187. PubMed ID: 29333751
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate Specificity and Isotypes of Monoclonal and Polyclonal Antibodies to Conjugated Tetrasaccharide, a Synthetic Analogue of Repeating Unit of Capsular Polysaccharide of Streptococcus Pneumoniae Serotype 14.
Kurbatova ЕА; Yakovleva IV; Akhmatova EА; Sukhova ЕV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Bull Exp Biol Med; 2019 Feb; 166(4):477-480. PubMed ID: 30788740
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
[TBL] [Abstract][Full Text] [Related]
12. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
13. A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against
Ravinder M; Liao KS; Cheng YY; Pawar S; Lin TL; Wang JT; Wu CY
J Org Chem; 2020 Dec; 85(24):15964-15997. PubMed ID: 33108196
[No Abstract] [Full Text] [Related]
14. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines.
Javed ; Mandal PK
Carbohydr Res; 2021 Apr; 502():108277. PubMed ID: 33743443
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides.
Parameswar AR; Park IH; Saksena R; Kovác P; Nahm MH; Demchenko AV
Chembiochem; 2009 Dec; 10(18):2893-9. PubMed ID: 19856369
[TBL] [Abstract][Full Text] [Related]
16. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
17. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
[TBL] [Abstract][Full Text] [Related]
18. Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.
Wang JY; Chang AH; Guttormsen HK; Rosas AL; Kasper DL
Vaccine; 2003 Mar; 21(11-12):1112-7. PubMed ID: 12559788
[TBL] [Abstract][Full Text] [Related]
19. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine.
Phalipon A; Costachel C; Grandjean C; Thuizat A; Guerreiro C; Tanguy M; Nato F; Vulliez-Le Normand B; Bélot F; Wright K; Marcel-Peyre V; Sansonetti PJ; Mulard LA
J Immunol; 2006 Feb; 176(3):1686-94. PubMed ID: 16424198
[TBL] [Abstract][Full Text] [Related]
20. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
Sun X; Stefanetti G; Berti F; Kasper DL
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):193-198. PubMed ID: 30510007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
